Induction therapy does not increase surgical morbidity after esophagectomy for cancer.
about
Pulmonary complications in patients with chronic obstructive pulmonary disease following transthoracic esophagectomyComplete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival.The effect of neoadjuvant chemoradiotherapy on airway colonization and postoperative respiratory complications in patients undergoing oesophagectomy for oesophageal cancerImpact of Neoadjuvant Chemoradiation on Short-Term Outcomes for Esophageal Squamous Cell Carcinoma Patients: A Meta-analysis.Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma: An Updated Meta-analysis.External validation of the Ferguson pulmonary risk score for predicting major pulmonary complications after oesophagectomy†.Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancerFour-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer.Is minimally invasive esophagectomy indicated for cancer?Influence of preoperative radiation field on postoperative leak rates in esophageal cancer patients after trimodality therapy.Update on staging and surgical treatment options for esophageal cancer.Multimodal treatment strategy for clinical T3 thoracic esophageal cancer.Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.Analysis of Intensity-Modulated Radiation Therapy (IMRT), Proton and 3D Conformal Radiotherapy (3D-CRT) for Reducing Perioperative Cardiopulmonary Complications in Esophageal Cancer Patients.Esophageal reconstruction using the terminal ileum and right colon in esophageal cancer surgery.Postoperative complications do not affect long-term outcome in esophageal cancer patients.
P2860
Q33868465-ED838D5C-A3B4-4255-BAE1-A76A93F05365Q34094802-41217F3C-2BF4-4B60-B6C1-25454DA53872Q35961777-FF3C47E9-84D7-4DC8-9FBA-708945AC4FCAQ36045600-83CCF290-6C8D-4EBB-8B7A-562BB7942945Q36221479-D4FE3BD9-3D58-4D2C-9F41-65914E754630Q36429589-682D710E-6AE0-4B7E-92BB-C51CE4BC326BQ36671857-3132A5CB-BBB5-48AB-8A57-017638158C3CQ37030546-2DE8C474-513C-4864-982B-4713D13F0BD6Q37256829-3FBAF191-1200-4782-BE9B-30A3072286C8Q37707375-C9DBDBEA-4455-42A4-BA3E-BA5A384B4812Q37864583-29C37160-268C-4C7C-BDCD-3861BF636F3EQ38128743-F9CFF9FD-1D6C-4FEA-ADFE-AD2514D4F885Q38367708-C98FA34C-97BB-4871-907D-60FB7EE07357Q41712007-55CAEDDE-C80B-4A13-AA0B-8B5A1BD48E47Q44660463-6EB5B9B6-E004-4A10-AE8E-CB139F1A1752Q44713290-5E984F8E-4F59-4706-B63A-1685444B142B
P2860
Induction therapy does not increase surgical morbidity after esophagectomy for cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Induction therapy does not increase surgical morbidity after esophagectomy for cancer.
@ast
Induction therapy does not increase surgical morbidity after esophagectomy for cancer.
@en
type
label
Induction therapy does not increase surgical morbidity after esophagectomy for cancer.
@ast
Induction therapy does not increase surgical morbidity after esophagectomy for cancer.
@en
prefLabel
Induction therapy does not increase surgical morbidity after esophagectomy for cancer.
@ast
Induction therapy does not increase surgical morbidity after esophagectomy for cancer.
@en
P2093
P1476
Induction therapy does not increase surgical morbidity after esophagectomy for cancer.
@en
P2093
Amy E Durkin
Frank C-F Lin
Mark K Ferguson
P304
P356
10.1016/J.ATHORACSUR.2004.04.081
P407
P577
2004-11-01T00:00:00Z